Measuring Health-Related Quality of Life in Patients with Cystic Fibrosis

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Healthcare Quality and Patient Safety".

Deadline for manuscript submissions: closed (1 August 2020) | Viewed by 134

Special Issue Editor


E-Mail Website
Guest Editor
Public Health and Preventive Medicine, Monash University, Level 3, 553 St Kilda Rd, Melbourne, VIC 3004, Australia
Interests: quality of life; PROMs; rare diseases; clinical quality registries; clinical trials; new drugs and treatments
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cystic fibrosis has undergone significant changes in the last few decades. In the mid-1900s, the majority of cystic fibrosis patients did not survive beyond infancy. Now, over half of patients are adults and life expectancy exceeds 40 in most developed countries. The changing demographics of cystic fibrosis has led to new challenges in both disease management and clinical research. Treatment burden has increased, such that treatments currently require two to four hours a day. The growing adult population encounters more difficulties balancing the symptom and treatment burden of the disease with work, education, or family demands. Therefore, there is an increasing requirement to examine and manage the psychosocial impacts of cystic fibrosis. Another challenge is posed by the relative healthiness of the modern cystic fibrosis population resulting in traditional endpoints in clinical trials such as forced expiratory volume in one second (FEV1) and frequency of pulmonary exacerbations having reduced sensitivity. A possible solution to these challenges is to monitor and collect data on health-related quality of life (HRQoL) and patient-reported outcome measures (PROMs). This Special Issue features a wide range of research papers on improving HRQoL, mental health issues, and capturing PROMs in pediatric and adult patient populations with cystic fibrosis.

Dr. Ruseckaite Rasa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cystic fibrosis
  • survival
  • mental health
  • quality of life
  • outcomes
  • PROMs

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop